A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Public ClinicalTrials.gov record NCT02693093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Single Dose PK and Safety Study With NI-03 Followed by a Phase 2, Randomized, Double-Blind, Parallel-Group Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 When Compared to Placebo in Subjects With Chronic Pancreatitis
Study identification
- NCT ID
- NCT02693093
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Kangen Pharmaceuticals, Inc
- Industry
- Enrollment
- 264 participants
Conditions and interventions
Conditions
Interventions
- NI-03 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 23, 2016
- Primary completion
- Sep 29, 2021
- Completion
- Dec 29, 2021
- Last update posted
- Dec 15, 2022
2016 – 2021
United States locations
- U.S. sites
- 28
- U.S. states
- 20
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas | Little Rock | Arkansas | 72204 | — |
| Kaiser Permanente Medical Group | Los Angeles | California | 90027 | — |
| University of Southern California, Keck School of Medicine | Los Angeles | California | 90033 | — |
| Stanford University School of Medicine | Stanford | California | 94305 | — |
| University of Colorado-Div of Gastroenterology and Hepatology | Aurora | Colorado | 80045 | — |
| Yale School of Medicine | New Haven | Connecticut | 06519 | — |
| University of Florida - Division of Gastroenterology | Gainesville | Florida | 32608 | — |
| Borland-Groover Clinic | Jacksonville | Florida | 32256 | — |
| Gastroenterology Group of Naples | Naples | Florida | 34102 | — |
| The Carle Foundation Hospital | Urbana | Illinois | 61801 | — |
| Indiana University - Indiana University Hospital | Indianapolis | Indiana | 46202-5149 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| UMass Memorial Medical Center | Worcester | Massachusetts | 01605 | — |
| Clinical Research Institute of Michigan, LLC | Chesterfield | Michigan | 48047 | — |
| Gastroenterology Associates of Western Michigan | Wyoming | Michigan | 49519 | — |
| Kansas City Research Institute | Kansas City | Missouri | 64131 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Columbia University School of Medicine | New York | New York | 10027 | — |
| PMG Research of Winston-Salem | Winston-Salem | North Carolina | 27103 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| Ohio State University (OSU) - Wexner Medical Center | Columbus | Ohio | 43210 | — |
| UPMC Presbyterian | Pittsburgh | Pennsylvania | 15213-2536 | — |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29425 | — |
| Texas Clinical Research Institute | Arlington | Texas | 76012 | — |
| Texas Tech University Health Sciences Center | El Paso | Texas | 79905 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Virginia Mason | Seattle | Washington | 98101 | — |
| Wisconsin Center for Advanced Research, a division of GI Associates LLC | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02693093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 15, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02693093 live on ClinicalTrials.gov.